Viral mediated gene delivery is a common practice to transduce normal cells into cancerous cells, such as the transfection of hematological stem cells with MSCV-BCR-AB-GFP-IRES vector. My question is how do we control the rate of cell transfection (some cells may have single copy while other more than one) as increase in copy number may result in resistance against therapy?